184 related articles for article (PubMed ID: 7515847)
21. Human monoclonal antibodies to viral peptides.
Sidorova E; Borisova T; Lyakisheva L; Rosen A
Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
[TBL] [Abstract][Full Text] [Related]
22. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
Vogel T; Kurth R; Norley S
J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
[TBL] [Abstract][Full Text] [Related]
23. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.
Teeuwsen VJ; Siebelink KH; Crush-Stanton S; Swerdlow B; Schalken JJ; Goudsmit J; van de Akker R; Stukart MJ; Uytdehaag FG; Osterhaus AD
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):381-92. PubMed ID: 1692724
[TBL] [Abstract][Full Text] [Related]
24. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA
Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
[TBL] [Abstract][Full Text] [Related]
26. Analysis of human antibody response to cholera vaccination by Epstein Barr virus transformation and human-human hybridoma production.
Ghosh S; Cannon CA; Campbell AM
J Clin Lab Immunol; 1987 Jul; 23(3):129-33. PubMed ID: 2444705
[TBL] [Abstract][Full Text] [Related]
27. In vitro immunization of human lymphocytes with human lung cancer cell line A549.
Kawahara H; Shirahata S; Tachibana H; Murakami H
Hum Antibodies Hybridomas; 1992 Jan; 3(1):8-13. PubMed ID: 1576323
[TBL] [Abstract][Full Text] [Related]
28. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
[TBL] [Abstract][Full Text] [Related]
29. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
[TBL] [Abstract][Full Text] [Related]
30. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NhMAb) production among infected Thais.
Akapirat S; Avihingsanon A; Ananworanich J; Schuetz A; Ramasoota P; Luplertlop N; Ono K; Ikuta K; Utachee P; Kameoka M; Leaungwutiwong P
Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):825-41. PubMed ID: 24437318
[TBL] [Abstract][Full Text] [Related]
31. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.
Amadori A; Zamarchi R; Ciminale V; Del Mistro A; Siervo S; Alberti A; Colombatti M; Chieco-Bianchi L
J Immunol; 1989 Oct; 143(7):2146-52. PubMed ID: 2476498
[TBL] [Abstract][Full Text] [Related]
32. Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.
Goudsmit J; Boucher CA; Meloen RH; Epstein LG; Smit L; van der Hoek L; Bakker M
AIDS; 1988 Jun; 2(3):157-64. PubMed ID: 2456084
[TBL] [Abstract][Full Text] [Related]
33. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
34. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines.
Robinson JE; Holton D; Pacheco-Morell S; Liu J; McMurdo H
AIDS Res Hum Retroviruses; 1990 May; 6(5):567-79. PubMed ID: 1694449
[TBL] [Abstract][Full Text] [Related]
35. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach.
Price KM; Cuthbertson AS; Varndell IM; Sheppard PW
Dev Biol Stand; 1990; 71():23-31. PubMed ID: 1698166
[TBL] [Abstract][Full Text] [Related]
36. In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display.
Dueñas M; Chin LT; Malmborg AC; Casalvilla R; Ohlin M; Borrebaeck CA
Immunology; 1996 Sep; 89(1):1-7. PubMed ID: 8911132
[TBL] [Abstract][Full Text] [Related]
37. Production of human monoclonal antibodies against HIV-1 peptides.
Bongertz V; Wigzell H; Rossi P
Braz J Med Biol Res; 1991; 24(8):815-8. PubMed ID: 1797270
[TBL] [Abstract][Full Text] [Related]
38. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
Larose Y; Tackaberry ES; Brodeur BR
Hum Antibodies Hybridomas; 1991 Apr; 2(2):67-73. PubMed ID: 1714785
[TBL] [Abstract][Full Text] [Related]
39. Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.
Fernández IM; Golding H; Benaissa-Trouw BJ; de Vos NM; Harmsen M; Nottet HS; Golding B; Puijk WC; Meloen RH; Snippe H; Kraaijeveld CA
Vaccine; 1998 Dec; 16(20):1936-40. PubMed ID: 9796047
[TBL] [Abstract][Full Text] [Related]
40. Human anti-pneumococci antibody produced by an Epstein Barr virus (EBV)-immortalized cell line.
Steinitz M; Tamir S; Goldfarb A
J Immunol; 1984 Feb; 132(2):877-82. PubMed ID: 6317751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
